We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pfizer Inc. said Wednesday it will continue to ramp up outsourcing of manufacturing as it faces the imminent patent expiration of top-selling drug Lipitor. CNN Money
